Form 4: Therapeutic Solutions International Director Acquires 10 Million Shares at Discount, Disposes of 187 Million Shares

Sentiment:

SEC Form 4 Filing


Thomas Ichim, a director of Therapeutic Solutions International, acquired 10 million shares of common stock at $0.0008 per share and disposed of 187 million shares on July 8, 2024.

Summary

  • On July 8, 2024, Thomas Ichim, a director of Therapeutic Solutions International, engaged in transactions involving the company's common stock.
  • Ichim acquired 10,000,000 shares at a price of $0.0008 per share.
  • Simultaneously, Ichim disposed of 187,000,000 shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it's a factual report of stock transactions. The impact on investor sentiment will depend on how the market interprets the director's actions.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency into the trading activities of company directors. The market will likely interpret the transactions based on the net effect and the reasons behind them, which are not disclosed in this filing.

Key Dates

DateDescription
07/08/2024Date of stock acquisition and disposal by Thomas Ichim

Keywords

Therapeutic Solutions International, TSOI, Form 4, Insider Trading, Beneficial Ownership, Thomas Ichim, Director, Stock Acquisition, Stock Disposal, SEC

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.